Hefei Lifeon Pharmaceutical's low P/E ratio is due to invest...
Hefei Lifeon Pharmaceutical's low P/E ratio is due to investors' expectations of limited future growth and weaker earnings compared to the market. The company's inferior earnings outlook is contributing to its low P/E.
Investors Don't See Light At End Of Hefei Lifeon Pharmaceutical Co., Ltd.'s (SZSE:003020) Tunnel And Push Stock Down 27%
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment